Hiscock & Barclay Welcomes New Of Counsel Thomas R. Slusarczyk
Syracuse, New York - June 21, 2013 - Thomas R. Slusarczyk has joined Hiscock & Barclay as Of Counsel in the Syracuse office.
Slusarczyk is a corporate and securities lawyer who represents public and private companies with securities matters (including, SEC registration statement filings, IPOs, reverse mergers, private investment in public equity (PIPE) transactions, rights offerings, Regulation D and S offerings, Sarbanes-Oxley compliance and blue sky filings), mergers & acquisitions, joint ventures, dispositions, and general corporate matters. He also advises public companies (both foreign and domestic) regarding compliance with its 1934 Exchange Act requirements, including all periodic filings on Forms 10-K, 10-Q and 8-K (Forms 20-F and 6-K for foreign private issuers), and proxy statements, as well as, other regulatory and other filing requirements with the SEC, NYSE, NASDAQ, NYSE AMEX and FINRA.
Prior to joining Hiscock & Barclay, Slusarczyk practiced with DLA Piper US in New York, working with clients such as Deutsche Bank AG and GE Healthcare. In 2011, he joined Anslow & Jaclin, LLP, representing public and private companies in corporate and securities matters.
Slusarczyk graduated from Western Michigan University with a bachelor of science degree in engineering and from Syracuse University College of Law, where he was an editor on the Syracuse Law Review, member of the Order of the Coif, and graduated in the top five percent of his class.
Hiscock & Barclay, LLP, listed as a “Top 250 Firm” by The National Law Journal, is a full-service, 200-attorney law firm, with offices throughout the major cities of New York State, as well as in Boston, Newark, N.J., Washington, D.C. and Toronto, providing comprehensive legal and business counsel to a diverse client base in 30 practice areas.
- General Obligations Law § 5-335 Prohibits Insurer’s Reduction in Disability Benefits
- Health Care Compliance and Responsibilities of Boards of Directors
- New York State Expands Opportunities for Industrial Hemp Production and Processing
- Employers Should Carefully Evaluate Their Policies Regarding Drug Testing and Employee Privacy Rights With Respect to Medical Marijuana Use